Bodybuilders secret to those bulkier muscles!!!
At what age should you use steroids? A steroid is a biologically active organic compound with four rings arranged in a specific molecular configuration. Steroids have two principal biological functions: as important components of cell membranes and as signaling molecules. The term “steroid” is used to refer to a wide variety of natural and synthetic…
Trenbolone – What is it? Trenbolone is an androgen and anabolic steroid (AAS) medication that is used in veterinary medicine, specifically to increase the profitability of livestock by promoting muscle growth in animals. Its off-label use by bodybuilders and athletes has been common since the 1980s. Common side effects in humans include masculinization (changes in…
All about Steroid Cycle Steroid cycles are one of the most popular methods used by athletes to improve their performance. However, there is a lot of misinformation out there about how they work and what risks they pose. In this article, we’ll dispel some of the myths and give you the facts about steroid cycles.…
What is a steroid cycle? A steroid is a type of organic compound that contains four rings arranged in a specific way. Steroids are naturally occurring in animals, plants, and fungi. They can also be man-made. Steroids have many different functions in the body. For example, they can help control how the body makes proteins.…
Most common steroids for sale There are many different types of steroids for sale, but the most common ones used for bodybuilding are oral and injectable. Oral steroids are taken in pill form, while injectable steroids are injected into the muscle. Both steroids can help increase muscle mass and strength but can also cause side…
I work at the University of Hull where I am Director of the Endo180 Cancer Team winner of the Educate North Research Team Of The Year award in 2016.
Before moving to Yorkshire I lived and worked in London.
I spent three years working as a graduate research assistant at King’s College London from 1992 to 1995. I then moved to Imperial College London where I was awarded my Ph.D. in 1998. My first post-doctoral work was conducted with Professor Gareth Jones at King’s College London from 1998 to 2001. My next five years of post-doctoral research was conducted with Professor Clare Isacke at the Institute of Cancer Research.
My first academic appointment was as Non-Clinical Lecturer with Professor Jonathan Waxman in the Faculty of Medicine at Imperial College London from 2006 to 2011. I was Senior Lecturer in The School of Biological, Biomedical & Environmental Sciences at the University of Hull from 2012 – 2016 and appointed Reader in 2016.
My research since 2001 has focused on understanding how the receptor Endo180 contributes to the different stages of cancer, and I am now using the latest technologies available to translate this knowledge into better survival rates for patients.
Endo180 plays fundamental roles in the pathology of breast cancer, prostate cancer, lung cancer, pancreatic cancer, liver cancer, glioblastoma, osteosarcoma and secondary bone cancer. More cancer types are likely to be added to this list as research progresses.
New cancer diagnostics and therapeutics are currently under development in my laboratory. These are based on our discovery that Endo180 is part of a molecular switch for aggressive cancer. This breakthrough was reported in Molecular Cancer Research a journal published by the American Association for Cancer Research in March 2015.
This Blog will keep you updated on all of the Endo180 related research being conducted throughout the world, as it translates from the laboratory bench to the bedsides of cancer patients.
Click Me How to study basement membrane stiffness as a biophysical trigger in prostate cancer Justin SturgeThursday, February 25, 2016 Congratulations to my co-authors Mercedes Rodriguez-Teja, Claudia Briet, Mitchell Clarke, Kamil Talar, Kai Wang, Mohammad A Mohammad, Guillermina Etchandy, Sage Pixie and Graeme Stasiuk on acceptance of our methodology paper by The Journal of Visualized…
Click Me ‘Monster molecule’ silenced in battle to combat cancer Justin SturgeWednesday, February 24, 2016 “Skeletal bone is a particularly attractive site for secondary tumours to grow and a final destination for cancer that has spread throughout the body. Cancer cells can thrive in this environment.” “We are excited about this finding as it could…
Click Me Meeting with Pancreatic Cancer UK tommorow to advise on research priorities Dr Justin SturgeMonday, September 26, 2016 This is the post content
Click Me Winner of Educate North Research Team Of The Year 2016 Dr Justin SturgeThursday, April 21, 2016 The Endo180 Cancer Team dedicate this award to Prince Rogers Nelson (7th June 1958 – 21st April 2016)